Developer docs
API playgroundTry for free, no card

Search company profiles

JCB Laboratories

Full company profile

uuid002ol89

Namestring
JCB Laboratories
Websiteurl
jcblabs.com
Company typeenum
Private
Founded yearint
2002
Descriptiontext

Fagron Sterile Services US (FSS), operating under or alongside the JCB Laboratories identity in the available source data, is a DEA- and FDA-registered 503B pharmaceutical outsourcing facility that compounds and repackages sterile medications for US hospitals, medical centers, and specialty clinical practices. The company produces pre-filled syringes, IV bags, and ready-to-administer sterile solutions across five service categories: Critical Care (e.g., phenylephrine IV bags), Labor & Delivery (oxytocin, epidural solutions), Ophthalmics (combo eye drops, mitomycin, moxifloxacin), Pain Management (bupivacaine, ropivacaine, fentanyl, hydromorphone), and Specialty Presentations (sterile L.E.T. Gel, mito-bladder syringes for USP <800> compliance, and repackaged bevacizumab/Avastin® in Daikyo Crystal Zenith® syringes).

Production runs on 268K+ ft² of cGMP-compliant capacity across three US facilities in Wichita, Kansas (headquarters), Boston, Massachusetts, and Austin, Texas, using semi-automated operations including Groninger automation for sterile filling. All batches are tested for sterility, particulate matter, and potency. Advanced TALLman lettering on labels aligns with ISMP, FDA, USP, and ASTM color standards to mitigate medication errors. The company is part of the global Fagron organization, which operates 4,000+ employees, 70+ facilities, and serves 30+ countries, leveraging 3,000+ suppliers for supply chain resiliency.

FSS sells direct to enterprise healthcare buyers via a field sales motion with a structured 4-step onboarding process (Explore, Consult, Set up account, Place order), quote-based pricing, free consultations, and an Instant Ship Program for in-stock medications. Customers include a National Group Purchasing Organization, state pharmacy regulators, and named major medical centers, with the company reporting it is trusted by thousands of clinicians supporting millions of patient procedures annually.

Short descriptiontext

Fagron Sterile Services US is a DEA- and FDA-registered 503B pharmaceutical outsourcing facility that compounds sterile medications across five service categories for US hospitals, medical centers, and specialty practices, operating 268K+ ft² of cGMP capacity across three US facilities.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersWichita, United States
HQ citystring
Wichita
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices3 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
sterile pharmaceutical compounding, 503B outsourcing services, hospital sterile preparations, pre-filled syringes, cGMP pharmaceutical manufacturing
Industry1 code
PRIMARYHLAIABAH
Generic Finished Dosage Form (FDF) Manufacturing
NAICS code3 codes
  • Pharmaceutical Preparation Manufacturing325412
  • Pharmaceutical and Medicine Manufacturing3254
  • Pharmaceutical and Medicine Manufacturing32541
SIC code1 code
  • Pharmaceutical Preparations2834
Product category
Sterile Pharmaceutical Compounding (503B Outsourcing)
Social media profiles2 records
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Pharmaceutical Compounding Products
TypeOne Time License
Description

Sale of high-quality sterile medication preparations including Critical Care, Labor & Delivery, Ophthalmics, Pain Management, and Specialty Presentations. Products include pre-filled syringes, IV bags, and ready-to-administer solutions.

fagronsterile.com
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels2 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Personnel, Operations, Supply Chain, Infrastructure, Technology or R&D, Marketing or Sales
Pricing details1 tier
1Contact sales for custom pricing
ModelOtherBilling cadencePay-as-you-go
Notes

Quote-based / Not publicly disclosed; free consultation available

fagronsterile.com
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

Fagron Sterile Services US is a DEA- and FDA-registered 503B pharmaceutical outsourcing facility that compounds and distributes sterile medication preparations to hospitals, medical centers, and specialty practices. Its portfolio spans pre-filled syringes, IV bags, and unit-of-use presentations across Critical Care, Labor & Delivery, Ophthalmics, Pain Management, and Specialty Presentations, all produced under cGMP-compliant operations inspected against 21 CFR 210 and 211 standards.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • Millions of patient procedures supported annually
+2 more records
Product overview1 text field

Fagron Sterile Services US is a DEA and FDA-registered 503B pharmaceutical outsourcing company offering a vertically integrated portfolio of sterile compounding services. The company operates across five service categories: Critical Care (pre-filled IV solutions like phenylephrine), Labor & Delivery (oxytocin, epidural solutions), Ophthalmics (combo eye drops, mitomycin, moxifloxacin), Pain Management (bupivacaine, ropivacaine, fentanyl), and Specialty Presentations (L.E.T. Gel, mito-bladder syringes, repackaged Avastin®). The Instant Ship Program provides in-stock medications ready for immediate shipment. All products are manufactured through 268K+ ft² of cGMP-compliant capacity across three facilities in Wichita, KS, Boston, MA, and Austin, TX.

Product and service9 records
1Critical Care Sterile Preparations
Category503B Sterile Compounding Service Category
Description

Pre-filled, ready-to-administer sterile solutions for surgical settings including phenylephrine IV bags, with advanced labeling featuring TALLman lettering to mitigate medication errors; targeted at hospitals and critical care departments.

2Labor & Delivery Sterile Preparations
Category503B Sterile Compounding Service Category
Description

High-quality sterile medications including oxytocin and epidural solutions supporting maternal and neonatal care in hospitals and birth centers.

3Ophthalmics Sterile Preparations
Category503B Sterile Compounding Service Category
Description

Comprehensive ophthalmic products including combination eye drops, mitomycin, and moxifloxacin for surgical and therapeutic applications in eye care practices and ophthalmic surgery centers.

4Pain Management Sterile Preparations
Category503B Sterile Compounding Service Category
Description

Preservative-free corticosteroids and anesthetics including bupivacaine, ropivacaine, fentanyl, and hydromorphone in unit-of-use presentations for pain management protocols and USP 800 compliance.

5Specialty Presentations
Category503B Sterile Compounding Service Category
Description

Innovative offerings including L.E.T. Gel (first and only sterile formulation), mito-bladder syringes for USP 800 compliance, and repackaged Avastin in Crystal Zenith syringes for specialty practices.

6Phenylephrine HCl 25mg/250mL IV Bag
Category503B Compounded Product
Description

Featured critical care product prepared through state-of-the-art semi-automated cGMP-compliant operations with advanced TALLman lettering labeling aligned with ISMP, FDA, USP, and ASTM standards.

7Bevacizumab (Avastin®) Injection Syringe
Category503B Compounded Product
Description

Repackaged bevacizumab (Avastin®) in Daikyo Crystal Zenith® syringe produced with Groninger automation through cGMP-compliant operations for ophthalmic and specialty practices.

8Instant Ship Program
Category503B Distribution Program
Description

In-stock, ready to ship medications for immediate delivery when needed, supporting clinicians with urgent medication requirements.

9503B Outsourcing Services
CategoryCore 503B Outsourcing Service
Description

DEA and FDA-registered pharmaceutical outsourcing including sterile medication preparation, repackaging, and manufacturing under cGMP-compliant 21 CFR 210 and 211 standards for healthcare facilities.

Scale indicator8 records

Each record includes

Type, Value, Description, Source

Recent move5 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Leiters is a 503B registered outsourcing facility specializing in sterile injectable compounding, including ready-to-administer preparations, directly comparable to FSS's core offerings in Critical Care and ophthalmics.

TypeBroad incumbent
Description

Patheon, part of Thermo Fisher's pharma services division, offers large-scale sterile injectable manufacturing and fill-finish services, representing a broader CDMO incumbent competing in the same end markets as FSS.

TypeDirect peer
Description

QuVa Pharma is a leading 503B outsourcing facility producing sterile injectable preparations for hospital systems, directly competing with FSS across Critical Care, Pain Management, and ophthalmic categories.

TypeBroad incumbent
Description

Hikma is a global sterile injectable manufacturer with significant US hospital channel presence. Its generic sterile injectable portfolio overlaps with FSS's Critical Care and Pain Management categories as a broader industry incumbent.

TypeDirect peer
Description

Empower Pharmacy operates 503A and 503B compounding operations serving hospitals and clinics with sterile preparations, overlapping with FSS in sterile injectable and ophthalmic categories.

TypeDirect peer
Description

AnazaoHealth is a 503B outsourcing facility producing sterile injectable and compounded preparations, with comparable focus on hospital and specialty practice customers.

TypeBroad incumbent
Description

Catalent is a large global CDMO offering sterile injectable fill-finish and pre-filled syringe manufacturing services. While much broader in scope, its sterile injectable capabilities overlap meaningfully with FSS's biologic repackaging and pre-filled syringe offerings.

TypeBroad incumbent
Description

Sagent Pharmaceuticals manufactures and distributes sterile injectable products with a focus on hospital and acute care settings, providing broader-incumbent competition in injectable categories where FSS operates.

9Pharmaceutics International (Pii)
TypeDirect peer
Description

Pii is a CDMO with 503B outsourcing capabilities producing sterile injectable and pre-filled syringe products, overlapping with FSS in hospital-facing sterile compounding services.

TypeDirect peer
Description

US Pharma Lab operates an FDA-inspected 503B outsourcing facility producing sterile injectable preparations for hospitals, directly competing with FSS in ready-to-administer solutions and pre-filled syringes.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat6 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers3 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment5 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile5 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
Compliance3 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

JCB Laboratories

Sterile Pharmaceutical Compounding (503B Outsourcing)jcblabs.com

Fagron Sterile Services US is a DEA- and FDA-registered 503B pharmaceutical outsourcing facility that compounds sterile medications across five service categories for US hospitals, medical centers, and specialty practices, operating 268K+ ft² of cGMP capacity across three US facilities.

What JCB Laboratories does

Fagron Sterile Services US (FSS), operating under or alongside the JCB Laboratories identity in the available source data, is a DEA- and FDA-registered 503B pharmaceutical outsourcing facility that compounds and repackages sterile medications for US hospitals, medical centers, and specialty clinical practices. The company produces pre-filled syringes, IV bags, and ready-to-administer sterile solutions across five service categories: Critical Care (e.g., phenylephrine IV bags), Labor & Delivery (oxytocin, epidural solutions), Ophthalmics (combo eye drops, mitomycin, moxifloxacin), Pain Management (bupivacaine, ropivacaine, fentanyl, hydromorphone), and Specialty Presentations (sterile L.E.T. Gel, mito-bladder syringes for USP <800> compliance, and repackaged bevacizumab/Avastin® in Daikyo Crystal Zenith® syringes).

Production runs on 268K+ ft² of cGMP-compliant capacity across three US facilities in Wichita, Kansas (headquarters), Boston, Massachusetts, and Austin, Texas, using semi-automated operations including Groninger automation for sterile filling. All batches are tested for sterility, particulate matter, and potency. Advanced TALLman lettering on labels aligns with ISMP, FDA, USP, and ASTM color standards to mitigate medication errors. The company is part of the global Fagron organization, which operates 4,000+ employees, 70+ facilities, and serves 30+ countries, leveraging 3,000+ suppliers for supply chain resiliency.

FSS sells direct to enterprise healthcare buyers via a field sales motion with a structured 4-step onboarding process (Explore, Consult, Set up account, Place order), quote-based pricing, free consultations, and an Instant Ship Program for in-stock medications. Customers include a National Group Purchasing Organization, state pharmacy regulators, and named major medical centers, with the company reporting it is trusted by thousands of clinicians supporting millions of patient procedures annually.

JCB Laboratories firmographics

Firmographics
Name
JCB Laboratories
Website
https://jcblabs.com
Company type
Private
Founded year
2002
Operating status
Operating
Headcount range
11–50 employees
Short description
Fagron Sterile Services US is a DEA- and FDA-registered 503B pharmaceutical outsourcing facility that compounds sterile medications across five service categories for US hospitals, medical centers, and specialty practices, operating 268K+ ft² of cGMP capacity across three US facilities.
Ownership category
akta.pro rank

JCB Laboratories industry classification

Industry
Product category
Sterile Pharmaceutical Compounding (503B Outsourcing)
NAICS
Pharmaceutical Preparation Manufacturing (325412), Pharmaceutical and Medicine Manufacturing (3254), Pharmaceutical and Medicine Manufacturing (32541)
SIC
Pharmaceutical Preparations (2834)
akta.pro industry
PRIMARYHLAIABAH
Generic Finished Dosage Form (FDF) Manufacturing

Keywords

  • Sterile pharmaceutical compounding
  • 503B outsourcing services
  • Hospital sterile preparations
  • Pre-filled syringes
  • CGMP pharmaceutical manufacturing

Where JCB Laboratories is headquartered

Location

Headquarters

HQ city
Wichita
HQ country
United States
HQ region
North America

Offices3 records

Markets served

JCB Laboratories business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Personnel, Operations, Supply Chain, Infrastructure, Technology or R&D, Marketing or Sales

Revenue model

  1. Pharmaceutical Compounding Products: Sale of high-quality sterile medication preparations including Critical Care, Labor & Delivery, Ophthalmics, Pain Management, and Specialty Presentations. Products include pre-filled syringes, IV bags, and ready-to-administer solutions.

Pricing tiers

ModelBillingPrice
OtherPay-as-you-goContact sales for custom pricing

Go-to-market motion1 record

Distribution channels2 records

Marketing channels4 records

JCB Laboratories product offering

Product offering

Core offering

Fagron Sterile Services US is a DEA- and FDA-registered 503B pharmaceutical outsourcing facility that compounds and distributes sterile medication preparations to hospitals, medical centers, and specialty practices. Its portfolio spans pre-filled syringes, IV bags, and unit-of-use presentations across Critical Care, Labor & Delivery, Ophthalmics, Pain Management, and Specialty Presentations, all produced under cGMP-compliant operations inspected against 21 CFR 210 and 211 standards.

Product overview

Fagron Sterile Services US is a DEA and FDA-registered 503B pharmaceutical outsourcing company offering a vertically integrated portfolio of sterile compounding services. The company operates across five service categories: Critical Care (pre-filled IV solutions like phenylephrine), Labor & Delivery (oxytocin, epidural solutions), Ophthalmics (combo eye drops, mitomycin, moxifloxacin), Pain Management (bupivacaine, ropivacaine, fentanyl), and Specialty Presentations (L.E.T. Gel, mito-bladder syringes, repackaged Avastin®). The Instant Ship Program provides in-stock medications ready for immediate shipment. All products are manufactured through 268K+ ft² of cGMP-compliant capacity across three facilities in Wichita, KS, Boston, MA, and Austin, TX.

Differentiator

Problem solved

Functional benefit

Products and services

  • Critical Care Sterile Preparations Pre-filled, ready-to-administer sterile solutions for surgical settings including phenylephrine IV bags, with advanced labeling featuring TALLman lettering to mitigate medication errors; targeted at hospitals and critical care departments.
  • Labor & Delivery Sterile Preparations High-quality sterile medications including oxytocin and epidural solutions supporting maternal and neonatal care in hospitals and birth centers.
  • Ophthalmics Sterile Preparations Comprehensive ophthalmic products including combination eye drops, mitomycin, and moxifloxacin for surgical and therapeutic applications in eye care practices and ophthalmic surgery centers.
  • Pain Management Sterile Preparations Preservative-free corticosteroids and anesthetics including bupivacaine, ropivacaine, fentanyl, and hydromorphone in unit-of-use presentations for pain management protocols and USP 800 compliance.
  • Specialty Presentations Innovative offerings including L.E.T. Gel (first and only sterile formulation), mito-bladder syringes for USP 800 compliance, and repackaged Avastin in Crystal Zenith syringes for specialty practices.
  • Phenylephrine HCl 25mg/250mL IV Bag Featured critical care product prepared through state-of-the-art semi-automated cGMP-compliant operations with advanced TALLman lettering labeling aligned with ISMP, FDA, USP, and ASTM standards.
  • Bevacizumab (Avastin®) Injection Syringe Repackaged bevacizumab (Avastin®) in Daikyo Crystal Zenith® syringe produced with Groninger automation through cGMP-compliant operations for ophthalmic and specialty practices.
  • Instant Ship Program In-stock, ready to ship medications for immediate delivery when needed, supporting clinicians with urgent medication requirements.
  • 503B Outsourcing Services DEA and FDA-registered pharmaceutical outsourcing including sterile medication preparation, repackaging, and manufacturing under cGMP-compliant 21 CFR 210 and 211 standards for healthcare facilities.

Quantifiable outcome

  • Millions of patient procedures supported annually
  • +2 more outcomes

Companies that use JCB Laboratories

Customer profile

Named customers3 records

Segments5 records

Ideal customer profiles5 records

JCB Laboratories technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature4 records

JCB Laboratories partnerships and signals

Strategic signal

Scale indicators8 records

Recent moves5 records

Expansion highlights5 records

JCB Laboratories competitors and assessment

Company assessment

Direct peers

  • Leiters: Leiters is a 503B registered outsourcing facility specializing in sterile injectable compounding, including ready-to-administer preparations, directly comparable to FSS's core offerings in Critical Care and ophthalmics.
  • QuVa Pharma: QuVa Pharma is a leading 503B outsourcing facility producing sterile injectable preparations for hospital systems, directly competing with FSS across Critical Care, Pain Management, and ophthalmic categories.
  • Empower Pharmacy: Empower Pharmacy operates 503A and 503B compounding operations serving hospitals and clinics with sterile preparations, overlapping with FSS in sterile injectable and ophthalmic categories.
  • AnazaoHealth: AnazaoHealth is a 503B outsourcing facility producing sterile injectable and compounded preparations, with comparable focus on hospital and specialty practice customers.
  • Pharmaceutics International (Pii): Pii is a CDMO with 503B outsourcing capabilities producing sterile injectable and pre-filled syringe products, overlapping with FSS in hospital-facing sterile compounding services.
  • US Pharma Lab: US Pharma Lab operates an FDA-inspected 503B outsourcing facility producing sterile injectable preparations for hospitals, directly competing with FSS in ready-to-administer solutions and pre-filled syringes.

Broad incumbents

  • Patheon (Thermo Fisher Scientific): Patheon, part of Thermo Fisher's pharma services division, offers large-scale sterile injectable manufacturing and fill-finish services, representing a broader CDMO incumbent competing in the same end markets as FSS.
  • Hikma Pharmaceuticals: Hikma is a global sterile injectable manufacturer with significant US hospital channel presence. Its generic sterile injectable portfolio overlaps with FSS's Critical Care and Pain Management categories as a broader industry incumbent.
  • Catalent: Catalent is a large global CDMO offering sterile injectable fill-finish and pre-filled syringe manufacturing services. While much broader in scope, its sterile injectable capabilities overlap meaningfully with FSS's biologic repackaging and pre-filled syringe offerings.
  • Sagent Pharmaceuticals: Sagent Pharmaceuticals manufactures and distributes sterile injectable products with a focus on hospital and acute care settings, providing broader-incumbent competition in injectable categories where FSS operates.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

JCB Laboratories social profiles

Digital presence

JCB Laboratories compliance and trust

Trust signal

Compliance3 records

JCB Laboratories financial estimates

Financial estimate

Revenue estimate

Valuation estimate

JCB Laboratories leadership team

Management profile

Number of profiles

JCB Laboratories funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

JCB Laboratories M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about JCB Laboratories

What does JCB Laboratories do?

Fagron Sterile Services US is a DEA- and FDA-registered 503B pharmaceutical outsourcing facility that compounds and distributes sterile medication preparations to hospitals, medical centers, and specialty practices. Its portfolio spans pre-filled syringes, IV bags, and unit-of-use presentations across Critical Care, Labor & Delivery, Ophthalmics, Pain Management, and Specialty Presentations, all produced under cGMP-compliant operations inspected against 21 CFR 210 and 211 standards.

Is JCB Laboratories a public or private company?

JCB Laboratories is a private company. It is classified as corporate owned and is currently operating.

When was JCB Laboratories founded?

JCB Laboratories was founded in 2002. It employs 11 to 50 people.

Where is JCB Laboratories based?

JCB Laboratories is headquartered in Wichita, United States, in the North America region.

How does JCB Laboratories make money?

One revenue line is on record: pharmaceutical Compounding Products.

Who are JCB Laboratories's main competitors?

Direct peers on record are Leiters, QuVa Pharma, Empower Pharmacy, AnazaoHealth, Pharmaceutics International (Pii) and US Pharma Lab. Broad incumbents are Patheon (Thermo Fisher Scientific), Hikma Pharmaceuticals, Catalent and Sagent Pharmaceuticals.

Does JCB Laboratories have an API?

No public API is recorded for JCB Laboratories.

What industry is JCB Laboratories in?

JCB Laboratories's product category is Sterile Pharmaceutical Compounding (503B Outsourcing). Its primary akta.pro industry code is HLAIABAH, Generic Finished Dosage Form (FDF) Manufacturing. Its NAICS code is 325412 and its SIC code is 2834.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales